S2Medical AB (publ) (FRA:S21)

Market Cap	929.60K +33.5%
Revenue (ttm)	1.39M +40.8%
Net Income	-247.47K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,325
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0085
Beta	n/a
RSI	48.54
Earnings Date	Feb 19, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2013
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S21

Financial Performance

Financial numbers in SEK